Charles Schwab Investment Management Inc. Grows Stock Holdings in The Beauty Health Company (NASDAQ:SKIN)

Charles Schwab Investment Management Inc. grew its stake in shares of The Beauty Health Company (NASDAQ:SKIN) by 7.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 688,365 shares of the company’s stock after acquiring an additional 45,525 shares during the period. Charles Schwab Investment Management Inc. owned 0.55% of Beauty Health worth $1,094,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. HighTower Advisors LLC purchased a new position in Beauty Health in the 3rd quarter worth approximately $121,000. Barclays PLC boosted its holdings in shares of Beauty Health by 224.7% in the 3rd quarter. Barclays PLC now owns 106,103 shares of the company’s stock worth $153,000 after purchasing an additional 73,425 shares in the last quarter. FMR LLC increased its position in shares of Beauty Health by 0.3% during the 3rd quarter. FMR LLC now owns 18,603,037 shares of the company’s stock valued at $26,788,000 after purchasing an additional 58,826 shares during the last quarter. Orion Portfolio Solutions LLC purchased a new position in shares of Beauty Health during the 3rd quarter valued at about $65,000. Finally, Jacobs Levy Equity Management Inc. lifted its position in Beauty Health by 1.1% in the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 2,499,652 shares of the company’s stock worth $3,599,000 after buying an additional 27,665 shares during the last quarter. 93.26% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Separately, Canaccord Genuity Group lowered their price objective on shares of Beauty Health from $1.75 to $1.50 and set a “hold” rating for the company in a report on Thursday, March 13th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and one has issued a buy rating to the company’s stock. According to data from MarketBeat.com, Beauty Health has an average rating of “Hold” and an average target price of $2.50.

Beauty Health Trading Down 2.9 %

Shares of SKIN stock opened at $1.32 on Monday. The stock has a market capitalization of $165.32 million, a P/E ratio of -3.14 and a beta of 0.84. The company has a current ratio of 6.56, a quick ratio of 5.57 and a debt-to-equity ratio of 9.23. The firm’s 50 day moving average is $1.51 and its 200 day moving average is $1.54. The Beauty Health Company has a 12-month low of $0.91 and a 12-month high of $4.48.

Beauty Health (NASDAQ:SKIN) last issued its quarterly earnings results on Wednesday, March 12th. The company reported ($0.08) EPS for the quarter, topping analysts’ consensus estimates of ($0.10) by $0.02. The business had revenue of $83.50 million during the quarter, compared to analysts’ expectations of $78.02 million. Beauty Health had a negative return on equity of 44.83% and a negative net margin of 8.11%. During the same quarter in the prior year, the business posted ($0.07) earnings per share. Research analysts expect that The Beauty Health Company will post -0.25 earnings per share for the current year.

Beauty Health Profile

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.